- Home
- TVTX vs DAVA Comparison
TVTX vs DAVA Comparison
Compare TVTX & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- DAVA
- Stock Information
- Founded
- TVTX 2008
- DAVA 2000
- Country
- TVTX United States
- DAVA United Kingdom
- Employees
- TVTX N/A
- DAVA N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- DAVA EDP Services
- Sector
- TVTX Health Care
- DAVA Technology
- Exchange
- TVTX Nasdaq
- DAVA Nasdaq
- Market Cap
- TVTX 1.3B
- DAVA 1.5B
- IPO Year
- TVTX N/A
- DAVA 2018
- Fundamental
- Price
- TVTX $17.72
- DAVA $26.88
- Analyst Decision
- TVTX Buy
- DAVA Buy
- Analyst Count
- TVTX 13
- DAVA 11
- Target Price
- TVTX $23.46
- DAVA $41.10
- AVG Volume (30 Days)
- TVTX 1.4M
- DAVA 560.8K
- Earning Date
- TVTX 10-31-2024
- DAVA 11-12-2024
- Dividend Yield
- TVTX N/A
- DAVA N/A
- EPS Growth
- TVTX N/A
- DAVA N/A
- EPS
- TVTX N/A
- DAVA 0.16
- Revenue
- TVTX $203,447,000.00
- DAVA $1,001,724,970.00
- Revenue This Year
- TVTX $62.45
- DAVA $10.55
- Revenue Next Year
- TVTX $59.30
- DAVA $10.35
- P/E Ratio
- TVTX N/A
- DAVA $167.84
- Revenue Growth
- TVTX 57.08
- DAVA N/A
- 52 Week Low
- TVTX $5.12
- DAVA $23.28
- 52 Week High
- TVTX $20.33
- DAVA $81.06
- Technical
- Relative Strength Index (RSI)
- TVTX 51.53
- DAVA 52.55
- Support Level
- TVTX $16.89
- DAVA $23.40
- Resistance Level
- TVTX $19.51
- DAVA $33.42
- Average True Range (ATR)
- TVTX 1.23
- DAVA 1.47
- MACD
- TVTX -0.16
- DAVA 0.46
- Stochastic Oscillator
- TVTX 26.69
- DAVA 34.73
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the U.K. and it continues to generate the majority of revenue in the U.K. and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.